BGT Bio-Gene Technology Limited
—Mkt Cap: —P/E: —1d ago
Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a s…
Industry Peers
Biotechnology$128.87BUSDP/E 29.6
$94.42BUSD
$81.99BUSDP/E 19.1
$53.47BUSDP/E 32.5
$53.22BUSDP/E 31.6
$44.02BUSDP/E 17.8
$42.56BUSDP/E 66.4
$40.57BUSD
$34.45BUSDP/E 30.4
$31.32BUSDP/E 39.3
$24.59BUSD
$23.32BUSDP/E 31.7
$23.26BUSDP/E 29.8
$22.96BUSDP/E 14.0
$22.66BUSD
$21.67BUSD
$15.57BUSDP/E 19.3
$14.91BUSDP/E 17.4
$13.92BUSDP/E 14.7
$13.79BUSDP/E 33.4
Key Statistics
Company
Market Cap—
Enterprise Value2.60M USD
Revenue (TTM)745.60K USD
Gross Profit-232.53K USD
Net Income (TTM)-1.61M USD
Revenue/Share0.0030 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU000000BGT8
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.62
EV/Revenue3.48
P/S5.28
P/B2.60
EPS (TTM)-0.01
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin68.81%
Oper. Margin-86.87%
EBITDA Margin-212.14%
Profit Margin-216.04%
ROE-111.50%
ROA-89.29%
Growth
Revenue Growth105.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.34M USD
CapEx (TTM)—
FCF Margin-104.18%
FCF Yield—
Net Debt-1.34M USD
Net Debt/EBITDA0.84
Balance Sheet
Debt/Equity—
Current Ratio4.78
Quick Ratio4.54
Book Value/Sh0.0050 AUD
Cash/Share0.0040 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.438.06M
Float242.06M
Insiders44.74%
Institutions0.00%
Technical
SMA 500.0175 AUD
SMA 2000.0256 AUD
Beta0.79
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)296.63K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—